Back to top

Analyst Blog

RocheHoldings Ltd. (RHHBY - Analyst Report) recently expressed its disappointment at the Institutional Shareholder Services’ (ISS) recommendation that Illumina Inc.’s (ILMN - Analyst Report) shareholders should not elect Roche’s independent director nominees to Illumina’s Board of Directors.

However, Roche said that it is pleased that ISS noted that Roche would make an excellent partner for Illumina, as the sequencing industry becomes more intertwined with the development of new drugs.

We note that last week Roche had issued a second letter to Illumina’s shareholders, requesting them to tender their shares to Roche for a payment of $51.00 a share. Roche’s second letter came after Illumina rejected Roche’s offer to acquire all its shares.

Since January, Roche has been trying to acquire Illumina, when it had first announced its bid to acquire all shares of Illumina at an offer price of $44.50 per share (aggregate value $5.7 billion) in cash. Then, on February 27, Roche extended the time-period for its bid to March 23 from February 24, 2012. In March, Roche further extended the time period for acquiring all outstanding shares of Illumina to April 20, 2012, from the previously announced date (March 23, 2012).

Additionally, in the last week of March, Roche increased its offer price for Illumina shares to $51.00 (aggregate value $6.7 billion) from $44.50 a share, while the other terms and conditions of the deal remained unchanged.

Roche believes that this acquisition will strengthen its position in the sequencing and microarrays market. Moreover, it will help address the growing demand for genetic/genomic solutions.

We currently have a Zacks #4 Rank (short-term Sell rating) on Roche.

Please login to or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research


Are you a new Zacks Member or a visitor to

Top Zacks Features

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
PLANAR SYST… PLNR 4.44 +5.21%
BITAUTO HOL… BITA 81.71 +5.12%
CTPARTNERS… CTP 16.66 +4.26%
CHINA BIOLO… CBPO 47.91 +3.30%
MALLINCKROD… MNK 72.94 +2.85%